158 related articles for article (PubMed ID: 38424177)
1. Combined clinical variable and radiomics of post-treatment total body scan for prediction of successful I-131 ablation in low-risk papillary thyroid carcinoma patients.
Chantadisai M; Wongwijitsook J; Ritlumlert N; Rakvongthai Y
Sci Rep; 2024 Feb; 14(1):5001. PubMed ID: 38424177
[TBL] [Abstract][Full Text] [Related]
2. Impact factors for the outcome of the first
Shangguan L; Fang S; Zhang P; Han S; Shen X; Geng Y; Luo D; Zhao C
Ann Nucl Med; 2019 Mar; 33(3):177-183. PubMed ID: 30515649
[TBL] [Abstract][Full Text] [Related]
3. Analysis of preoperative computed tomography radiomics and clinical factors for predicting postsurgical recurrence of papillary thyroid carcinoma.
Xu H; Wu W; Zhao Y; Liu Z; Bao D; Li L; Lin M; Zhang Y; Zhao X; Luo D
Cancer Imaging; 2023 Dec; 23(1):118. PubMed ID: 38098119
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of thyroglobulin changes for the efficacy of thyroid remnant ablation.
Savelli G; Chiti A; Rodari M; Schreiner F; Maccauro M; Aliberti G; Gerali A; Bombardieri E
Tumori; 2001; 87(1):42-6. PubMed ID: 11669557
[TBL] [Abstract][Full Text] [Related]
5. Preoperative prediction of extrathyroidal extension: radiomics signature based on multimodal ultrasound to papillary thyroid carcinoma.
Wan F; He W; Zhang W; Zhang Y; Zhang H; Guang Y
BMC Med Imaging; 2023 Jul; 23(1):96. PubMed ID: 37474935
[TBL] [Abstract][Full Text] [Related]
6. Computed Tomography-Based Radiomics Model to Predict Central Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma: A Multicenter Study.
Li J; Wu X; Mao N; Zheng G; Zhang H; Mou Y; Jia C; Mi J; Song X
Front Endocrinol (Lausanne); 2021; 12():741698. PubMed ID: 34745008
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Pre-Ablation Stimulated Thyroglobulin in Children and Adolescents with Differentiated Thyroid Cancer.
Liu L; Zhang X; Tian T; Huang R; Liu B
Thyroid; 2020 Jul; 30(7):1017-1024. PubMed ID: 31964278
[No Abstract] [Full Text] [Related]
8. Radiomics based on multiparametric MRI for extrathyroidal extension feature prediction in papillary thyroid cancer.
Wei R; Wang H; Wang L; Hu W; Sun X; Dai Z; Zhu J; Li H; Ge Y; Song B
BMC Med Imaging; 2021 Feb; 21(1):20. PubMed ID: 33563233
[TBL] [Abstract][Full Text] [Related]
9. Predicting central lymph node metastasis in patients with papillary thyroid carcinoma based on ultrasound radiomic and morphological features analysis.
Yan X; Mou X; Yang Y; Ren J; Zhou X; Huang Y; Yuan H
BMC Med Imaging; 2023 Aug; 23(1):111. PubMed ID: 37620767
[TBL] [Abstract][Full Text] [Related]
10. Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma.
Muratet JP; Giraud P; Daver A; Minier JF; Gamelin E; Larra F
J Nucl Med; 1997 Sep; 38(9):1362-8. PubMed ID: 9293788
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma.
Lee HJ; Rha SY; Jo YS; Kim SM; Ku BJ; Shong M; Kim YK; Ro HK
Am J Clin Oncol; 2007 Feb; 30(1):63-8. PubMed ID: 17278897
[TBL] [Abstract][Full Text] [Related]
12. Low-dose radioiodine therapy for patients with intermediate- to high-risk differentiated thyroid cancer.
Abe K; Ishizaki U; Ono T; Horiuchi K; Kanaya K; Sakai S; Okamoto T
Ann Nucl Med; 2020 Feb; 34(2):144-151. PubMed ID: 31834567
[TBL] [Abstract][Full Text] [Related]
13. Determining patient selection tool and response predictor for outpatient 30 mCi radioiodine ablation dose in non-metastatic differentiated thyroid carcinoma: a Japanese perspective.
Higuchi T; Achmad A; Binh DD; Bhattarai A; Tsushima Y
Endocr J; 2018 Mar; 65(3):345-357. PubMed ID: 29343651
[TBL] [Abstract][Full Text] [Related]
14. CT Radiomics-Based Nomogram for Predicting the Lateral Neck Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Prospective Multicenter Study.
Dong L; Han X; Yu P; Zhang W; Wang C; Sun Q; Song F; Zhang H; Zheng G; Mao N; Song X
Acad Radiol; 2023 Dec; 30(12):3032-3046. PubMed ID: 37210266
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of an increase in the serum thyroglobulin level at the time of the first ablative radioiodine treatment in patients with differentiated thyroid cancer.
Bernier MO; Morel O; Rodien P; Muratet JP; Giraud P; Rohmer V; Jeanguillaume C; Bigorgne JC; Jallet P
Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1418-21. PubMed ID: 16133388
[TBL] [Abstract][Full Text] [Related]
16. Lithium as an adjuvant in the postoperative ablation of remnant tissue in low-risk thyroid carcinoma.
Yamazaki CA; Padovani RP; Biscolla RP; Ikejiri ES; Marchetti RR; Castiglioni ML; Matsumura LK; Maciel RM; Furlanetto RP
Thyroid; 2012 Oct; 22(10):1002-6. PubMed ID: 22953991
[TBL] [Abstract][Full Text] [Related]
17. Radioiodine Uptake and Thyroglobulin-Guided Radioiodine Remnant Ablation in Patients with Differentiated Thyroid Cancer: A Prospective, Randomized, Open-Label, Controlled Trial.
Jin Y; Ruan M; Cheng L; Fu H; Liu M; Sheng S; Chen L
Thyroid; 2019 Jan; 29(1):101-110. PubMed ID: 30560716
[TBL] [Abstract][Full Text] [Related]
18. Outpatient ablation treatment with two doses of 30 mCi of radioactive iodine for non-low-risk papillary thyroid cancer.
Uno A; Takeda H; Mori M; Yamamoto Y; Takenaka Y; Enomoto K; Takeda N
J Med Invest; 2023; 70(1.2):17-21. PubMed ID: 37164716
[TBL] [Abstract][Full Text] [Related]
19. Using ultrasound features and radiomics analysis to predict lymph node metastasis in patients with thyroid cancer.
Li F; Pan D; He Y; Wu Y; Peng J; Li J; Wang Y; Yang H; Chen J
BMC Surg; 2020 Dec; 20(1):315. PubMed ID: 33276765
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound images-based deep learning radiomics nomogram for preoperative prediction of
Yu J; Zhang Y; Zheng J; Jia M; Lu X
Front Endocrinol (Lausanne); 2022; 13():1062571. PubMed ID: 36605945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
